Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ANDA User Fee Agreement Expected To Be Finished in Early September

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA wants the commitment letter and draft legislation ready for internal clearance by Sept. 9.
Advertisement

Related Content

ANDA Backlog Fee Non-Payment: FDA Will Weigh Fairness Vs. Public Health
ANDA Backlog Fee Non-Payment: FDA Will Weigh Fairness Vs. Public Health
ANDA User Fee Negotiations Finished; Backlog To Be Mostly Cleared By Year Five
ANDA User Fee Performance Metrics Revealed
ANDA User Fee Performance Metrics Revealed
ANDA User Fee Negotiations Finished; Backlog To Be Mostly Cleared By Year Five
FDA, Industry Reach Agreement On Major Portions Of Generic User Fee Program
ANDA User Fees: Negotiators Close To Agreement, But Backlog Is Sticking Point
ANDA User Fees: Negotiators Close To Agreement, But Backlog Is Sticking Point

Topics

Advertisement
UsernamePublicRestriction

Register

PS072694

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel